Thus, we recommend that a highly PD-L1–positive (≥50% positive tumour cells) NSCLC sample should be used instead to provide a dynamic range of PD-L1 staining for intensity and spatial distribution. The gene discussed is CD274; the disease is non-small cell lung carcinoma.